Article | June 8, 2017

Expanding Single-Use Biomanufacturing Into New Locations

Source: GE Healthcare Life Sciences
biopharmaceutical manufacturing

As an industry, expanding biomanufacturing capacity to new locations is most often to support access to new markets. This could be as a contract manufacturer wanting to locate near a certain customer base or as a pharmaceutical or biotechnology company wanting to establish local in-house production.

Expanding to become an operation with multiple manufacturing sites also improves security of supply, offering the ability to manufacture the same product at more than one location, providing you have installed duplicate capacity.